The MOHCCN Clinician-Scientist Award provides outstanding early-career clinician-scientists with funding to support high-quality research in precision oncology. The award is designed to support early-career investigators as they develop their careers as independent clinician scientists, in close collaboration and mentorship with established MOHCCN-funded teams. The final awardees were selected after a peer-review committee reviewed the 13 full applications received from clinician-scientists across Canada.

In addition to new funding, the researchers will have access to expertise, data and resources generated by the Network. In turn, they will contribute knowledge and data from their projects to the Network, helping to accelerate the implementation of precision medicine for cancer in Canada.

Learn more about this competition and how to apply, here.

Currently Funded Projects

• Dr. Ana Nikolic, University of Calgary (Calgary) for: The evolution of transcriptional cellular state dynamics in recurrent glioblastoma
• Dr. Robert Grant, University Health Network (Toronto) for: Mapping pancreatic cancer biology to drug responses
• Dr. Bertrand Routy, Centre de Recherche du Centre hospitalier de l'Université de Montréal (Montreal) for: How microbiomes influence intratumour immune contexture and response to immune-checkpoint inhibitors in patients with non-small cell lung cancer
• Dr. Philippe Lefrançois, Lady Davis Institute, McGill University and Jewish General Hospital (Montreal) for: Understanding the genomic and cellular landscapes of advanced basal cell carcinoma (BCC)